Top Blood Draw Supply Suppliers for U.S. Hospitals: Distributors and Manufacturers

Summary

• Major U.S. hospital suppliers include McKesson Medical-Surgical, Medline Industries, Cardinal Health, Henry Schein Medical, and Owens & Minor, while manufacturers such as BD, Greiner Bio-One, Terumo, Sarstedt, and ICU Medical produce many of the actual blood collection products.
• Hospitals typically purchase complete blood-draw programs rather than individual tubes, including evacuated blood collection tubes, needles, holders, syringes, tourniquets, safety devices, specimen bags, labels, and transport materials.
• Price, product availability, FDA compliance, safety-engineering requirements, laboratory compatibility, distribution capacity, and contract terms are the most important factors when selecting a supplier in the United States.

Hospitals in the United States purchase blood draw supplies through a combination of national medical distributors, specialized laboratory suppliers, direct manufacturers, group purchasing organizations, and regional distributors. Because blood collection is performed in emergency departments, inpatient units, outpatient laboratories, physician practices, intensive care units, operating rooms, and mobile care settings, hospitals generally need a broad and dependable supply program rather than a single product vendor.

The most frequently purchased products include evacuated blood collection tubes, Blood Culture bottles, safety needles, winged blood collection sets, needle holders, syringes, lancets, tourniquets, alcohol or Chlorhexidine preparations, gauze, adhesive dressings, specimen labels, transport bags, sharps containers, and point-of-care collection devices. A large hospital may use millions of tubes and collection devices each year, making purchasing decisions important not only for supply budgets but also for patient safety, laboratory accuracy, worker protection, and turnaround time.

The U.S. market is large and highly regulated. The U.S. Food and Drug Administration classifies many blood collection devices as medical devices, and hospitals must also comply with Occupational Safety and Health Administration requirements, Clinical Laboratory Improvement Amendments requirements, state Regulations, accreditation standards, and internal infection-prevention policies. As a result, the lowest unit price is rarely the only consideration when hospitals evaluate suppliers.

National Medical Distributors Serving Hospitals

National distributors are often the primary purchasing channel for hospitals because they can combine products from multiple manufacturers, maintain regional warehouses, provide electronic ordering systems, and support large health-system contracts. They may sell products under manufacturer brands, private-label brands, or a combination of both.

McKesson Medical-Surgical

McKesson Medical-Surgical is one of the largest distributors of medical-surgical products in the United States. Its catalog includes blood collection tubes, needles, syringes, safety products, specimen containers, laboratory supplies, personal protective equipment, and general clinical consumables.

Hospitals and integrated delivery networks often use McKesson because it can supply many departments through a consolidated purchasing arrangement. A facility purchasing blood collection products from McKesson may also obtain exam gloves, wound-care supplies, incontinence products, respiratory items, and office or pharmacy materials through the same distribution infrastructure.

McKesson’s scale can be useful when a hospital needs standardized products across several locations. It may also support barcode-based ordering, inventory management, scheduled deliveries, and electronic data interchange. However, hospitals should verify whether a specific blood collection item is supplied directly by McKesson, manufactured under a private label, or sourced from another manufacturer. Product equivalence should be confirmed through laboratory validation rather than assumed from a similar catalog description.

Medline Industries

Medline Industries is a major U.S. manufacturer and distributor of medical supplies. It offers blood collection and specimen-management products alongside a very broad portfolio covering operating-room supplies, examination products, infection prevention, laboratory items, and patient-care equipment.

Medline is especially relevant to hospitals seeking a supplier that can combine direct manufacturing with distribution and clinical implementation support. Its blood draw portfolio may include safety needles, blood collection sets, tube holders, tourniquets, specimen transport bags, labels, gauze, prep products, and related items. Hospitals may also evaluate Medline’s private-label products when looking for cost savings or supply standardization.

A key benefit of working with a large integrated supplier is the ability to negotiate a systemwide program. A hospital network can potentially standardize collection products between its central laboratory, emergency department, inpatient units, and affiliated clinics. The purchasing team should nevertheless examine clinical requirements carefully, since the ideal tube or needle for one department may not be appropriate for every patient population or testing platform.

Cardinal Health

Cardinal Health is another major medical distributor supplying hospitals, laboratories, ambulatory facilities, and other healthcare organizations. Its medical products business covers a broad range of consumables, including blood collection and laboratory supplies.

Hospitals may purchase blood draw products through Cardinal Health as part of a larger medical-surgical contract. Common categories include evacuated tubes, Blood Culture collection products, needles, syringes, safety devices, specimen containers, and transport supplies. Cardinal Health also manufactures or distributes products used in medication delivery, operating rooms, patient care, and infection prevention.

For a large health system, Cardinal Health can be attractive because of national distribution capabilities and established hospital procurement relationships. The most important evaluation issues include fill rates, back-order communication, substitution policies, delivery frequency, product traceability, and the ability to maintain stock during periods of high demand.

Owens & Minor

Owens & Minor provides medical products and logistics services to hospitals and health systems throughout the United States. Its offerings include medical and surgical supplies, personal protective equipment, laboratory-related products, and other disposable items used in patient care.

Hospitals may use Owens & Minor for blood draw products as part of a broader distribution agreement. The company’s logistics capabilities can be particularly important for multi-site systems that need scheduled deliveries, inventory visibility, and standardized replenishment procedures.

When considering Owens & Minor or another national distributor, a hospital should assess the distributor’s performance at the local level. National scale does not automatically guarantee the same service quality in every market. Delivery schedules, warehouse proximity, regional demand, and contract allocation can affect actual availability.

Henry Schein Medical

Henry Schein Medical is a large healthcare distributor that serves physicians, outpatient facilities, laboratories, and selected institutional customers. Its product range includes medical examination supplies, needles, syringes, specimen containers, laboratory consumables, and other products relevant to blood collection.

Henry Schein is often more visible in physician-office and ambulatory markets, but its catalog and distribution capabilities can also be useful to hospital-owned clinics, outpatient laboratories, urgent-care sites, and smaller hospitals. Organizations with a mixed network of hospitals and ambulatory locations may compare Henry Schein with larger hospital-focused distributors to determine which supplier offers the best combination of pricing, delivery, and product availability.

Manufacturers That Supply Blood Collection Products Directly

Distributors are convenient, but hospitals frequently negotiate directly with manufacturers for high-volume or technically important products. Direct manufacturer relationships can be useful when a hospital is standardizing tubes across multiple laboratory analyzers, introducing a new safety needle, or implementing a blood conservation program.

Becton, Dickinson and Company

Becton, Dickinson and Company, commonly known as BD, is one of the most recognized manufacturers of blood collection and specimen-management products. Its portfolio includes evacuated blood collection tubes, safety needles, winged blood collection sets, Blood Culture products, tube holders, syringes, lancets, and other devices used in diagnostic specimen collection.

BD’s Vacutainer product family is widely used in U.S. hospitals and clinical laboratories. The product range includes tubes with different additives, gels, clot activators, and specialized configurations. BD also manufactures safety-engineered devices designed to reduce needlestick risk.

Hospitals evaluating BD products should confirm tube compatibility with the laboratory’s analyzers, test menus, sample-volume requirements, centrifugation procedures, and specimen stability rules. Changing tube brands can affect specimen quality, fill volume, gel behavior, additive concentration, and testing performance. Any significant change should be reviewed through laboratory validation and medical staff or pathology leadership processes.

Greiner Bio-One

Greiner Bio-One is an international manufacturer with a substantial presence in the U.S. clinical laboratory market. Its VACUETTE product line includes evacuated blood collection tubes, needles, holders, urine containers, and other specimen collection products.

Greiner Bio-One is a common alternative to BD for hospitals seeking competitive pricing, dual sourcing, or product standardization across a particular laboratory network. Its products are used in hospitals, reference laboratories, outpatient centers, and physician offices.

When comparing Greiner Bio-One products with other brands, purchasing teams should focus on more than tube color. Color conventions are broadly recognized, but additive type, fill volume, material, closure design, labeling, and compatibility with automated laboratory systems are equally important.

Terumo Blood and Cell Technologies

Terumo Blood and Cell Technologies supplies blood collection, processing, and transfusion-related technologies. Its product portfolio is particularly relevant to blood centers, transfusion services, and organizations involved in blood component collection and processing, although certain collection products may also be relevant to hospital laboratories and specialty services.

Hospitals should distinguish between routine diagnostic blood draw supplies and products used for blood donation, apheresis, transfusion, or cellular therapy. These categories have different technical requirements, regulatory controls, and purchasing processes. Terumo may be more relevant to the latter categories than to everyday Venipuncture on a medical-surgical unit.

Sarstedt

Sarstedt manufactures laboratory and specimen-collection products, including blood collection tubes, needles, urine containers, specimen transport systems, and laboratory consumables. Its products are used by hospitals, laboratories, research organizations, and outpatient providers.

Sarstedt may be considered by hospitals seeking alternatives for specialized specimen collection, pediatric applications, small-volume testing, or laboratory workflows requiring particular tube formats. As with any manufacturer change, the laboratory must confirm that the product works with existing instruments and meets the requirements of each test method.

ICU Medical

ICU Medical is known for Infusion Therapy and critical-care products, but it also offers products relevant to blood sampling and vascular access. In intensive care and inpatient settings, blood sampling may be performed from arterial lines, central venous catheters, and other access devices rather than through routine peripheral Venipuncture.

Products used for closed blood sampling, line access, and blood conservation can help reduce repeated Venipuncture and limit blood loss in critically ill patients. Hospitals should evaluate dead-space volume, contamination risk, compatibility with existing catheters, infection-prevention procedures, and staff training before adopting these devices.

Specialized Safety and Phlebotomy Suppliers

Some suppliers concentrate on phlebotomy, needlestick prevention, or specimen collection rather than distributing every category of hospital product. These companies can be valuable when a facility needs technical expertise or a focused product evaluation.

Safety-engineered needle manufacturers

Several manufacturers produce safety needles, retractable needles, winged blood collection sets, and needleless or low-exposure systems. Examples include BD, Retractable Technologies, Smiths Medical products now associated with ICU Medical, and other specialized device manufacturers.

Safety-engineered devices are important because occupational exposure to blood and body fluids remains a major healthcare concern. OSHA’s bloodborne pathogens standard requires employers to use engineering and work-practice controls and to evaluate safer medical devices where appropriate. Hospitals also maintain exposure-control plans and involve frontline healthcare workers in the selection and evaluation of safety devices.

Product selection may depend on activation method, one-handed operation, visual confirmation of safety activation, needle size, tubing length, flashback visibility, compatibility with holders, and performance with difficult venous access. A low-cost device that staff find difficult to activate may create more risk than a higher-priced device with better usability.

Point-of-care and specialty collection suppliers

Hospitals also purchase blood collection supplies for Point-Of-Care Testing, neonatal care, oncology, dialysis, blood gas analysis, and home or ambulatory services. Specialty suppliers may provide capillary collection systems, microtainers, blood gas syringes, heel-stick lancets, and small-volume specimen containers.

These products are especially important in neonatal and pediatric care, where excessive blood loss can contribute to anemia. A 2023 review published in the medical literature noted that repeated diagnostic blood sampling is a recognized contributor to hospital-acquired anemia, particularly among intensive-care patients. The precise impact varies by patient population, but it supports the use of low-volume tubes, closed sampling systems, and blood conservation practices when clinically appropriate.

Group Purchasing Organizations and Contract-Based Purchasing

Many U.S. hospitals do not negotiate every supply purchase independently. They participate in group purchasing organizations, commonly called GPOs, which negotiate contracts on behalf of member hospitals and healthcare systems.

Prominent GPOs in the United States include Vizient, Premier, HealthTrust Purchasing Group, and Intalere-related contracting arrangements now incorporated into other industry structures. A GPO may negotiate pricing, rebates, product tiers, service requirements, and distribution terms for blood collection products. Hospitals may purchase from a contracted manufacturer through a distributor, directly from the manufacturer, or through a combination of channels.

GPO participation can produce economies of scale. The healthcare Supply Chain has long relied on aggregated purchasing volume, and federal healthcare spending data show that hospitals collectively account for a substantial share of U.S. healthcare expenditures. The Centers for Medicare & Medicaid Services reported national health expenditures of approximately $4.9 trillion in 2023, with hospital care representing roughly 30 percent of total spending. Even small reductions in unit cost can therefore have significant effects when multiplied across millions of collection devices.

However, contract price is only one part of the total cost. Hospitals should also examine:

1. Whether the product is available through the preferred distributor.
2. Whether the contract includes minimum purchase commitments.
3. Whether rebates depend on market share or product conversion.
4. Whether the supplier can support all hospital locations.
5. Whether the manufacturer has a reliable history of regulatory compliance and product availability.
6. Whether the contract permits substitution during shortages.
7. Whether conversion costs, staff education, and laboratory validation are included in the financial analysis.

What Blood Draw Supplies Do Hospitals Purchase?

A hospital’s blood collection program usually includes far more than tubes and needles. A complete inventory may contain dozens of product categories, each with different specifications and reorder patterns.

1. Evacuated blood collection tubes, including serum, plasma, EDTA, citrate, Heparin, fluoride, and specialty tubes.
2. Blood Culture bottles and collection accessories used for microbiology testing.
3. Safety needles in multiple gauges and lengths.
4. Winged blood collection sets, often called butterfly sets.
5. Single-use needle holders and reusable holder systems where permitted by policy.
6. Blood collection syringes and blood gas syringes.
7. Capillary tubes, lancets, microtainers, and heel-stick products.
8. Tourniquets, including disposable and reusable types.
9. Alcohol pads, Chlorhexidine preparations, povidone-iodine products, and other skin antiseptics.
10. Gauze, cotton balls, adhesive bandages, tape, and pressure dressings.
11. Specimen labels, label printers, barcode wristbands, and positive patient-identification materials.
12. Leak-resistant specimen bags and biohazard transport packaging.
13. Sharps containers and disposal products.
14. Specimen racks, trays, carts, and phlebotomy collection organizers.
15. Personal protective equipment, including gloves, masks, gowns, and eye protection.

The exact inventory depends on the hospital’s patient mix and laboratory services. A trauma center may require more Blood Culture and arterial sampling products. A neonatal intensive care unit may need large quantities of microcollection devices. An outpatient laboratory may use more winged sets and routine evacuated tubes. A cancer center may need specialized access and sampling supplies for ports and central lines.

How Hospitals Evaluate Blood Draw Suppliers

Purchasing committees generally combine input from supply-chain managers, laboratory directors, phlebotomy supervisors, infection-prevention specialists, nursing leaders, occupational-health staff, clinicians, and finance departments. The process should evaluate clinical performance and operational reliability together.

Regulatory and quality requirements

Hospitals should confirm that products are legally marketed for their intended use in the United States. Depending on the device, this may involve FDA clearance, registration, listing, or other regulatory status. The purchasing organization should request manufacturer documentation, instructions for use, lot traceability information, shelf-life data, and quality certifications where applicable.

Suppliers should also have procedures for handling recalls, field safety notices, complaints, and adverse-event reports. The FDA’s device recall database has recorded hundreds of medical-device recalls in many years, demonstrating why hospitals need a documented recall-management process. A supplier should be able to identify affected lots quickly and provide replacement products without disrupting patient care.

Product availability and shortage resilience

Blood collection supplies experienced significant disruption during the Covid-19 pandemic. At different times, hospitals reported shortages or allocation limits affecting tubes, swabs, personal protective equipment, and other laboratory consumables. Although conditions change, the experience demonstrated that even ordinary disposable products can become constrained by raw-material shortages, transportation delays, manufacturing interruptions, labor shortages, and sudden increases in testing volume.

Hospitals should ask suppliers about manufacturing locations, domestic inventory, backup production sites, allocation policies, average lead times, and emergency-order procedures. Dual sourcing can reduce risk, although it may increase complexity because different tubes or devices may require separate validation and staff training.

Cost and total economic value

The purchase price of a tube or needle is only one component of total cost. A more complete analysis includes freight, storage, inventory carrying costs, waste, failed collections, redraws, Needlestick Injuries, staff time, laboratory revalidation, and product conversions.

For example, a Specimen Rejection caused by hemolysis or an underfilled citrate tube may require a redraw. The cost includes a new collection device, phlebotomist time, nursing or laboratory labor, delayed treatment, patient dissatisfaction, and potentially longer length of stay. A supplier offering slightly higher-priced products may produce lower total cost if its products reduce redraw rates or improve Workflow.

Clinical usability

Clinical usability should be tested in real collection environments. A product that performs well in a demonstration may be less effective when used with elderly patients, pediatric patients, patients with fragile veins, or patients receiving Anticoagulant therapy.

Evaluation teams commonly review needle bevel design, safety activation, visibility of blood flashback, tube vacuum consistency, label adhesion, ease of tube inversion, packaging, and compatibility with existing collection trays. Staff feedback is important because phlebotomists and nurses use these products repeatedly and can identify Workflow problems quickly.

Important U.S. Standards and Operational Considerations

Blood draw suppliers must support hospitals operating within a complex framework of U.S. standards. OSHA regulates occupational exposure to bloodborne pathogens and requires employers to implement exposure-control measures. The Clinical Laboratory Improvement Amendments regulate laboratory testing and quality systems. The Joint Commission, College of American Pathologists, state health departments, and other accreditation or oversight bodies may impose additional requirements.

Patient identification is another critical issue. The Joint Commission has consistently identified patient identification as a central national safety concern. Blood specimens must be labeled correctly at the point of collection, and hospitals commonly use two patient identifiers, barcode scanning, bedside label printing, and electronic order verification to reduce identification errors.

Suppliers can support these goals by offering compatible barcode labels, printers, specimen bags, and collection carts. However, technology does not replace proper procedure. Staff must still verify the patient, match the order to the specimen, label the tube in the patient’s presence, and document collection according to hospital policy.

Hospitals should also examine packaging and waste. The Environmental Protection Agency and state authorities regulate aspects of medical waste management, while sharps containers must be suitable for the devices being discarded. Excess packaging can increase waste volume, whereas inadequate packaging can create contamination or injury risks.

Domestic, Regional, and Online Sources

Not every hospital obtains products from a national distributor. Regional medical-supply companies may provide faster local service, customized delivery schedules, or specialized account support. Some rural hospitals and critical-access hospitals use regional distributors because they need smaller order quantities and more flexible delivery arrangements.

Online medical-supply marketplaces and e-commerce distributors also sell phlebotomy products in the United States. These channels can be useful for small clinics, research organizations, occupational-health providers, and emergency purchases. Large hospitals, however, usually require more extensive controls, including approved-vendor status, lot tracking, temperature or storage documentation where relevant, insurance verification, product authenticity checks, and integration with procurement systems.

Hospitals should be cautious about gray-market or unauthorized products. A low price may reflect expired inventory, improper storage, unclear provenance, incomplete recall support, or counterfeit packaging. Medical-supply purchasing departments should verify the seller’s identity, manufacturer authorization, return policy, lot information, and regulatory documentation before purchasing clinical-use products.

Questions to Ask a Potential Supplier

A structured request-for-proposal process helps hospitals compare suppliers consistently. The following questions can be included in a sourcing review:

1. Which manufacturers and product families do you distribute?
2. What percentage of routine orders are shipped complete and on time?
3. Where are the products manufactured and warehoused?
4. What is the typical lead time for standard and emergency orders?
5. How are allocations handled during shortages?
6. Can you provide lot-level traceability and recall notifications?
7. What FDA and quality documentation is available?
8. Can products be delivered to multiple hospital locations?
9. Do you support electronic ordering, barcode scanning, and inventory reporting?
10. What are the minimum order quantities and freight charges?
11. Can you provide samples for clinical evaluation?
12. What training is available for safety-device conversion?
13. How are damaged, expired, or incorrect products handled?
14. Can you provide usage data and recommendations for reducing waste?
15. Are private-label products equivalent to branded products for the intended tests and procedures?

Practical Purchasing Strategy for U.S. Hospitals

The most effective strategy is usually a combination of standardization and flexibility. Hospitals can standardize routine tubes, needles, holders, labels, and collection procedures across departments while retaining specialized products for pediatrics, intensive care, oncology, blood gases, and other clinical areas.

A hospital should begin by analyzing twelve months of purchasing and utilization data. The review should identify annual quantities, stockouts, emergency purchases, expired inventory, product substitutions, Specimen Rejection rates, redraw rates, and needlestick incidents. The hospital can then determine which products represent the greatest financial or clinical opportunity.

The next step is to establish a multidisciplinary evaluation team. Representatives from laboratory medicine, phlebotomy, nursing, Supply Chain, infection prevention, occupational health, and finance should participate. Products should be tested under normal working conditions, and the evaluation should measure both user satisfaction and objective outcomes.

After a supplier is selected, the hospital should create a transition plan. A product conversion may require updated procedures, staff education, laboratory validation, electronic catalog changes, inventory depletion plans, and communication with outpatient or affiliated facilities. A phased conversion is often safer than replacing every product on the same day.

Performance should be reviewed after implementation. Useful measures include fill rate, back-order frequency, emergency orders, average delivery time, stockout days, Specimen Rejection rates, redraw rates, staff injuries, product waste, and total cost per collected specimen. These metrics help determine whether a contract is delivering value beyond its negotiated price.

Conclusion

The principal suppliers of blood draw supplies to U.S. hospitals include national distributors such as McKesson Medical-Surgical, Medline Industries, Cardinal Health, Owens & Minor, and Henry Schein Medical. Hospitals also purchase directly from manufacturers such as BD, Greiner Bio-One, Terumo Blood and Cell Technologies, Sarstedt, ICU Medical, and specialized safety-device companies.

Group purchasing organizations, regional distributors, and approved online suppliers provide additional purchasing channels. The best supplier depends on the hospital’s size, laboratory systems, patient population, contract structure, geographic footprint, and need for specialized collection products.

Because blood draw supplies directly affect specimen quality and healthcare-worker safety, hospitals should evaluate suppliers using a total-value approach. Regulatory compliance, reliable availability, product compatibility, staff usability, recall support, inventory resilience, and clinical outcomes should receive at least as much attention as unit price. A carefully managed supplier program can reduce waste, protect staff, support accurate testing, and help ensure that essential blood collection materials are available whenever patients need care.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on the topics. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Related Videos